Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases.

Item

http://www.wikidata.org/entity/Q38154628

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases.

@en

type

Item

label

Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases.

@en

prefLabel

Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases.

@en

P1476

Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases.

@en

P2093

Bao-Zhu Li

http://www.w3.org/2001/XMLSchema#string

Bin Mei

http://www.w3.org/2001/XMLSchema#string

Bing Chen

http://www.w3.org/2001/XMLSchema#string

Dong-Qing Ye

http://www.w3.org/2001/XMLSchema#string

Guo-Jun Yang

http://www.w3.org/2001/XMLSchema#string

Hua Yao

http://www.w3.org/2001/XMLSchema#string

Jin-Hui Tao

http://www.w3.org/2001/XMLSchema#string

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Jun-Wei Yan

http://www.w3.org/2001/XMLSchema#string

Wen-Jia Peng

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

Crystal Structure of IL-17 Receptor B SEFIR Domain

Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis

Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation.

Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study.

Celastrus-derived celastrol suppresses autoimmune arthritis by modulating antigen-induced cellular and humoral effector responses

SM934 treated lupus-prone NZB × NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development.

Expression of interleukin-17 is correlated with interferon-α expression in cutaneous lesions of lupus erythematosus.

A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma.

P304

29-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.2013.843669

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24147601

http://www.w3.org/2001/XMLSchema#string